10th RWE, Market Access, Pricing & Reimbursement Global Congress 2024 Europe

Dr. Levine has three decades of experience in the healthcare sector at Mayo Clinic. For the last 5 years he has been President of Fondation Ipsen, an international science foundation focused on Rare Disease innovation. With a background in wearable technologies, data gathering and data analytics, and with more than 100 patents and trademarks, Levine helped found 35 companies (17 to Series A and 1 IPO). He was the Innovator of the Year in the state of Minnesota, the World Trade Fair and NASA. Under the Mayo Clinic NEAT Trademarks Levine’s team delivered scalable health solutions to 72 US corporations. A great deal of James’ work focuses on biotech development, scalable health solutions and business opportunities in underserved countries. The UNESCO World Report on Science which he sponsored in his current role, facilitated business development (without personal gain) in underserved regions in the United States, and in the Democratic Republic of Congo (DRC), Cote d’Ivoire, Afghanistan, Jamaica, Asia, Kenya and India. Consulting to four USA Presidents, the State Department, US Army and internationally, Levine in 2018 was awarded the President’s Medal for promoting social embeddedness. A physician and scientist, Levine has published more than 200 articles, six papers in Science and Nature plus articles in journals such as, the New England Journal of Medicine, Lancet and JAMA. He has written four books published in 19 languages in 37 countries. 300 million people live with rare diseases without effective cures. Sustainable solutions require the efficient use of capital to maximize impact and minimize suffering.